FTH
Faeth Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$40.05
+2.69%Margins
Gross margin
2740.8%
EBITDA margin
4028.0%
EBIT margin
4098.5%
Net margin
4030.7%
FCF margin
698.0%
-113.0%
Return on equity
-103.3%
Return on assets
-114.6%
Return on invested capital
-0.02x
Asset turnover
-$33.9M
Cash from operations
$7.22
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026